Compare WYY & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WYY | HYFT |
|---|---|---|
| Founded | 1991 | 1983 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.1M | 55.1M |
| IPO Year | 2005 | N/A |
| Metric | WYY | HYFT |
|---|---|---|
| Price | $5.04 | $1.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $8.67 | $5.00 |
| AVG Volume (30 Days) | 30.0K | ★ 202.9K |
| Earning Date | 05-14-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $150,545,364.00 | N/A |
| Revenue This Year | $14.41 | N/A |
| Revenue Next Year | $11.41 | $29.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.59 | N/A |
| 52 Week Low | $2.80 | $0.99 |
| 52 Week High | $7.55 | $3.00 |
| Indicator | WYY | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 55.32 |
| Support Level | $4.95 | $1.02 |
| Resistance Level | $5.85 | $1.31 |
| Average True Range (ATR) | 0.29 | 0.11 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 59.99 | 58.51 |
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.